+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Interferons Market Report 2025 - Product Thumbnail Image

Interferons Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
From
Interleukin Inhibitors Market Report 2025 - Product Thumbnail Image

Interleukin Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Central Nervous System Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Central Nervous System Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 186 Pages
  • Global
From
From
Alpha Mannosidosis Market Report 2025 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Loading Indicator